// App-Quantinova.ai

P6-09-15 : Mechanism of drug resistance in relation to sites of metastases: Meta-analyses of randomized controlled trials in advanced breast cancer

Researchers

Presenter

  • S Niraula

Principal Investigators

  • A Ocana

Medical Centers

  • Translational Oncology Unit, Albacete University Hospital, Albacete, Spain

  • University of Manitoba, Cancer Care Manitoba, Winnipeg, MB, Canada

Locations

  • Spain

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Breast cancer

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved